Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

David Scharfs Positive Outlook on OneMain Holdings and Increased Price Target

Elaine Mendonca by Elaine Mendonca
January 12, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On January 12, 2024, David Scharf, an esteemed Wall Street analyst at JMP Securities, expressed his positive outlook on OneMain Holdings (NYSE: OMF). Scharf maintains a Market Outperform rating on the stock and has increased the price target from $46 to $53. This aligns with the average one-year price target for OneMain Holdings, which stands at $52.96. Notably, analysts’ forecasts for the stock range from a low of $41.41 to a high of $65.10.

With a keen focus on the financial sector, Scharf covers a total of 33 stocks. His success rate of 54.42% further solidifies his reputation as a knowledgeable and reliable analyst in the industry.

OMF Stock Price Declines Slightly on January 12, 2024: Factors to Consider for Investment Decisions

On January 12, 2024, OneMain Holdings Inc. (OMF) experienced a slight decline in its stock price. The price of OMF shares decreased by $0.11 since the market last closed, representing a drop of 0.22%. The closing price on the previous day was $49.75. Additionally, the stock experienced a drop of $0.15 in pre-market trading. It is important for investors to consider various factors, such as market trends, investor sentiment, and company-specific news, before making any investment decisions. While OMF has been trading near the top of its 52-week range and above its 200-day simple moving average, the decline in price on January 12 should be closely monitored to determine its significance. Conducting a thorough analysis of OMF’s financials, market conditions, and recent news or events is advisable, and consulting with a financial advisor or professional can provide valuable insights and guidance.

OneMain Holdings Inc. (OMF): Mixed Performance in Stock Market Operations with Impressive Q4 Rebound

On January 12, 2024, OneMain Holdings Inc. (OMF) displayed mixed performance in its stock market operations. The company’s financials, as reported by CNN Money, showed that while the total revenue remained flat since the previous year, it witnessed a modest increase of 3.84% in the last quarter. Similarly, the net income experienced a significant decline of 33.18% over the year, but rebounded impressively with an 88.35% increase in the last quarter. The earnings per share (EPS) also saw a decline of 28.54% over the year, followed by a remarkable increase of 88.19% in the last quarter.

Tags: OMF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Analyst Downgrades 89bio Rating and Sets 15 Price Target

Finance_Accounting

JMP Securities Analyst Raises Price Target for Open Lending Maintains Market Outperform Rating

Finance_Capitalistic

JMP Securities Analyst Maintains Positive Outlook on LegalZoomcom with Slight Price Target Adjustment

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com